Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Therapeutic Antibodies and Proteins market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Therapeutic Antibodies and Proteinsmarket, defines the market attractiveness level of Recombinant Therapeutic Antibodies and Proteins market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Therapeutic Antibodies and Proteins industry, describes the types of Recombinant Therapeutic Antibodies and Proteins market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Therapeutic Antibodies and Proteins market and the development prospects and opportunities of Recombinant Therapeutic Antibodies and Proteins industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Therapeutic Antibodies and Proteins market in Chapter 13.
By Player:
Biogen
Roche
Pfizer
Sanofi
Amgen
Novo Nordisk
Abbott
Johnson and Johnson
Eli Lilly
Merck
By Type:
Plasma Protein
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others
By End-User:
Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Disease
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Therapeutic Antibodies and Proteins Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Therapeutic Antibodies and Proteins Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Therapeutic Antibodies and Proteins Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Therapeutic Antibodies and Proteins Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Therapeutic Antibodies and Proteins Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Therapeutic Antibodies and Proteins Consumption (2017-2022)
-
7.2 United States Recombinant Therapeutic Antibodies and Proteins Consumption (2017-2022)
-
7.3 Europe Recombinant Therapeutic Antibodies and Proteins Consumption (2017-2022)
-
7.4 China Recombinant Therapeutic Antibodies and Proteins Consumption (2017-2022)
-
7.5 Japan Recombinant Therapeutic Antibodies and Proteins Consumption (2017-2022)
-
7.6 India Recombinant Therapeutic Antibodies and Proteins Consumption (2017-2022)
-
7.7 South Korea Recombinant Therapeutic Antibodies and Proteins Consumption (2017-2022)
8 Region and Country-wise Recombinant Therapeutic Antibodies and Proteins Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Therapeutic Antibodies and Proteins Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Therapeutic Antibodies and Proteins Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Therapeutic Antibodies and Proteins Consumption Forecast (2022-2028)
-
8.4 China Recombinant Therapeutic Antibodies and Proteins Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Therapeutic Antibodies and Proteins Consumption Forecast (2022-2028)
-
8.6 India Recombinant Therapeutic Antibodies and Proteins Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Therapeutic Antibodies and Proteins Consumption Forecast (2022-2028)
9 Global Recombinant Therapeutic Antibodies and Proteins Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Plasma Protein Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fusion Proteins Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hormones Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Enzyme Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Coagulation Factors Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hematology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Immunology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Endocrinology Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Global Recombinant Therapeutic Antibodies and Proteins Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Plasma Protein Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fusion Proteins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Hormones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Enzyme Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Therapeutic Antibodies and Proteins Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Therapeutic Antibodies and Proteins Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Therapeutic Antibodies and Proteins Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Therapeutic Antibodies and Proteins Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Therapeutic Antibodies and Proteins Market Competitive Analysis
-
14.1 Biogen
-
14.1.1 Biogen Company Details
-
14.1.2 Biogen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.2 Roche
-
14.2.1 Roche Company Details
-
14.2.2 Roche Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.6 Novo Nordisk
-
14.6.1 Novo Nordisk Company Details
-
14.6.2 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.7 Abbott
-
14.7.1 Abbott Company Details
-
14.7.2 Abbott Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbott Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.8 Johnson and Johnson
-
14.8.1 Johnson and Johnson Company Details
-
14.8.2 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.9 Eli Lilly
-
14.9.1 Eli Lilly Company Details
-
14.9.2 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product and Service
-
14.10 Merck
-
14.10.1 Merck Company Details
-
14.10.2 Merck Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck Recombinant Therapeutic Antibodies and Proteins Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Therapeutic Antibodies and Proteins
-
Figure Recombinant Therapeutic Antibodies and Proteins Picture
-
Table Global Recombinant Therapeutic Antibodies and Proteins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Therapeutic Antibodies and Proteins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Therapeutic Antibodies and Proteins Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Therapeutic Antibodies and Proteins Consumption by Country (2017-2022)
-
Figure United States Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Therapeutic Antibodies and Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Therapeutic Antibodies and Proteins Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Therapeutic Antibodies and Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plasma Protein Consumption and Growth Rate (2017-2022)
-
Figure Global Fusion Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Consumption and Growth Rate (2017-2022)
-
Figure Global Coagulation Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Hematology Consumption and Growth Rate (2017-2022)
-
Figure Global Immunology Consumption and Growth Rate (2017-2022)
-
Figure Global Endocrinology Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Plasma Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fusion Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Therapeutic Antibodies and Proteins Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Therapeutic Antibodies and Proteins Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Recombinant Therapeutic Antibodies and Proteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Recombinant Therapeutic Antibodies and Proteins Product and Service
-
